Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$4.78
+0.0800 (+1.70%)
At Close: May 09, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $4.28 $5.69 Thursday, 9th May 2024 MBRX stock ended at $4.78. This is 1.70% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 9.54% from a day low at $4.61 to a day high of $5.05.
90 days $0.400 $6.23
52 weeks $0.338 $6.23

Historical Moleculin Biotech Inc prices

Date Open High Low Close Volume
Dec 14, 2023 $0.544 $0.603 $0.544 $0.601 295 948
Dec 13, 2023 $0.512 $0.540 $0.501 $0.527 112 431
Dec 12, 2023 $0.513 $0.535 $0.500 $0.510 45 955
Dec 11, 2023 $0.538 $0.559 $0.506 $0.506 235 423
Dec 08, 2023 $0.500 $0.550 $0.490 $0.550 259 471
Dec 07, 2023 $0.557 $0.590 $0.501 $0.522 112 824
Dec 06, 2023 $0.598 $0.598 $0.560 $0.571 50 552
Dec 05, 2023 $0.590 $0.610 $0.586 $0.590 41 530
Dec 04, 2023 $0.610 $0.610 $0.580 $0.593 58 470
Dec 01, 2023 $0.602 $0.610 $0.580 $0.610 52 263
Nov 30, 2023 $0.565 $0.614 $0.565 $0.599 74 422
Nov 29, 2023 $0.598 $0.598 $0.575 $0.575 62 134
Nov 28, 2023 $0.575 $0.600 $0.561 $0.580 63 524
Nov 27, 2023 $0.570 $0.595 $0.540 $0.551 129 494
Nov 24, 2023 $0.536 $0.590 $0.535 $0.561 28 527
Nov 22, 2023 $0.521 $0.570 $0.521 $0.551 84 927
Nov 21, 2023 $0.540 $0.570 $0.522 $0.522 43 943
Nov 20, 2023 $0.572 $0.610 $0.538 $0.541 138 788
Nov 17, 2023 $0.601 $0.632 $0.540 $0.590 187 198
Nov 16, 2023 $0.570 $0.620 $0.560 $0.611 107 754
Nov 15, 2023 $0.540 $0.589 $0.530 $0.570 123 023
Nov 14, 2023 $0.547 $0.593 $0.542 $0.550 135 953
Nov 13, 2023 $0.598 $0.645 $0.550 $0.576 1 504 584
Nov 10, 2023 $0.508 $0.547 $0.504 $0.540 69 138
Nov 09, 2023 $0.544 $0.550 $0.493 $0.538 62 623
Click to get the best stock tips daily for free!

About Moleculin Biotech Inc

Moleculin Biotech Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial fo... MBRX Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
BNDX May 03 0.247% $48.68
BBCA May 03 0.99% $65.44
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
INVH May 03 0.90% $34.39
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT